Altria Group narrows FY25 adjusted EPS view to $5.35-$5.45 from $5.30-$5.45

Consensus $5.38. The company said, “We narrow our guidance for 2025 full-year adjusted diluted EPS to be in a range of $5.35 to $5.45, representing a growth rate of 3.0% to 5.0% from a base of $5.19 in 2024. We expect EPS growth to moderate as we lap the lower share count associated with the 2024 accelerated share repurchase program completion and the Master Settlement Agreement legal fund expiration benefit in the fourth quarter. Our guidance contemplates the current estimated impact of increased tariffs on our costs, based on presently available information about tariffs. In addition, our guidance assumes limited impact on combustible and e-vapor product volumes from enforcement efforts against products that have evaded the regulatory process and that ACE does not return to the marketplace this year. The guidance range also includes the reinvestment of anticipated cost savings related to our previously announced Optimize & Accelerate initiative and lower expected net periodic benefit income. While our 2025 full-year adjusted EPS guidance accounts for a range of scenarios, the external environment remains dynamic. We will continue to monitor conditions related to the economy, including the cumulative impact of inflation and increased tariffs, adult tobacco consumer dynamics, including purchasing patterns and adoption of smoke-free products, illicit product enforcement and regulatory, litigation and legislative developments. Our 2025 full-year adjusted diluted EPS guidance range includes planned investments in support of our Vision, such as marketplace activities in support of our smoke-free products and continued smoke-free product research, development and regulatory preparation expenses. This guidance range excludes the per share impacts related to charges associated with our Initiative. We continue to expect our 2025 full-year adjusted effective tax rate to be in a range of 23% to 24%, our 2025 capital expenditures to be between $175 million and $225 million and our 2025 depreciation and amortization expenses to be approximately $290 million.”